Formycon AG

14
Strong Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000A1EWVY8
EUR
25.55
2.7 (11.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Formycon AG Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-129.00
79.00
49.00
-14.00
-5.00
-2.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-11.00
-12.00
-3.00
-1.00
0.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-22.00
-9.00
-18.00
-13.00
-5.00
-1.00
Cash Flow from Investing Activities
-2.00
-17.00
-37.00
-3.00
0.00
-5.00
Cash Flow from Financing Activities
40.00
44.00
40.00
0.00
25.00
17.00
Net Cash Inflow / Outflow
14.00
17.00
-15.00
-16.00
19.00
10.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Formycon AG
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Profit Before Tax
-129.079
170.486
-299.00
-175.71%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-11.82
-20.444
9.00
42.18%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-22.958
152.257
-174.00
-115.08%
Cash Flow from Investing Activities
-2.635
-34.154
32.00
92.28%
Cash Flow from Financing Activities
40.391
-155.508
195.00
125.97%
Net Cash Inflow / Outflow
14.798
-37.442
51.00
139.52%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
-0.037
0.00
100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -144.21% vs 50.51% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-22.96
-9.40
-144.21%